Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3254591000168112 | Ezetimibe (LAPL) (ezetimibe 10 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3254601000168117 | Ezetimibe (LAPL) 10 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ezetimibe (LAPL) 10 mg tablet | Is a | Ezetimibe (LAPL) | true | Inferred relationship | Some | ||
| Ezetimibe (LAPL) 10 mg tablet | Is a | ezetimibe 10 mg tablet | true | Inferred relationship | Some | ||
| Ezetimibe (LAPL) 10 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ezetimibe (LAPL) 10 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Ezetimibe (LAPL) 10 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1356032723 | |
| Ezetimibe (LAPL) 10 mg tablet | has Australian BoSS | ezetimibe | true | Inferred relationship | Some | 1356032722 | |
| Ezetimibe (LAPL) 10 mg tablet | has intended active ingredient | ezetimibe | true | Inferred relationship | Some | 1356032722 |
Reference Sets
Trade product unit of use reference set
FHIR